ShouTi Strengthens Board With Appointment of Daniel G. Welch as Chairman
Accomplished biotechnology executive brings over 40 years of commercial and leadership experience across multinational pharmaceutical…
4 years ago
Renesas Ships 1 Billionth Device From RX Family of 32-bit Microcontrollers
Renesas Xtreme (RX) Microcontrollers Are Used in Wide Range of Consumer, Industrial and IoT Applications…
4 years ago
Aptorum Group Receives FDA Orphan Drug Designation for its SACT-1 Repurposed Drug For The Treatment of Neuroblastoma
NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--#Neuroblastoma--Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris:…
4 years ago
AMTD International Acquires Global Fashion Media Group L’Officiel Inc SAS
Dr. Calvin Choi, Founder of AMTD International, Chairman of AMTD Group, Appointed Lead Chairman of…
4 years ago
Juicy Stakes prove good things come in threes
New games, Free Spins and Cashback Specials SYDNEY--(BUSINESS WIRE)--Three is the magic number at Juicy…
4 years ago
Reconstruction Agency: Invitation to Online Tour “TSUNAGARU TOHOKU Iwate & Miyagi, and Fukushima”
Reconstruction Agency: “Fiscal 2021 Information Dissemination Project for Reconstruction of Disaster-Affected Areas From the Great…
4 years ago
WNS Announces Fiscal 2022 Third Quarter Earnings, Revises Full Year Guidance
NEW YORK & MUMBAI, India--(BUSINESS WIRE)--#BPM--WNS (Holdings) Limited (WNS) (NYSE: WNS), a leading provider of…
4 years ago
Mead Johnson Nutrition Hong Kong’s Omnichannel Consumer Engagement Wins HKB Greater Bay Area Enterprise Award
Mega launch of Enfa A+ NeuroPro upgraded formula receives wide recognition for successful online to…
4 years ago
Axion Global Asset Management secures regulatory approval to manage cryptocurrency funds
The Smart Beta Fund provides secure and diversified exposure to “Large-cap" Cryptocurrency Opportunities HONG KONG…
4 years ago
BeiGene Announces Acceptance of a Supplemental New Drug Application in China for BRUKINSA (zanubrutinib) in Waldenström’s Macroglobulinemia
BRUKINSA received the China NMPA approval for the treatment of patients with relapsed or refractory…
4 years ago